Page Title
Clinical Trial Finder
Observational Closed to Enrollment
Observational study of adults with cystic fibrosis for colorectal cancer screening (NICE-CF) (NICE-CF )
This observational study will compare stool-based testing to colonoscopy for colorectal cancer screening in people with CF. The study includes the collection of stool samples at home and a clinical screening colonoscopy.
Eligibility
See other primary eligibility criteria for more information.
-
Age:
18 Years to 75 Years -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Other Primary Eligibility Criteria
Adults with CF 40 years of age or older, without history of transplant, or adults with CF age 30 or older who have had a transplant. Adults must be eligible for routine colon cancer screening and referred for screening or surveillance colonoscopy for colorectal cancer.
Study Design
-
Study Type: ?more info
Observational -
Randomized Study: ?more info
No -
Placebo Controlled: ?more info
No -
Length of Participation:
6 months -
Number of Study Visits:
2
Additional Information
-
Phase: ?more info
Not Applicable -
Study Sponsor: ?more info
Hachem, Christine -
Study Drugs:
N/A
Study Sites
-
Closed to Enrollment
California
Stanford University Medical Center, STANFORD , CA 94305
-
Closed to Enrollment
California
University of California Los Angeles, Santa Monica, CA 90404
-
Closed to Enrollment
Colorado
National Jewish Health, Denver, CO 80206
-
Closed to Enrollment
Florida
University of Miami, Miami, FL 33136
-
Closed to Enrollment
Kansas
University of Kansas Medical Center, Kansas City, KS 66160
-
Closed to Enrollment
Maryland
Johns Hopkins University, Baltimore, MD 21205
-
Closed to Enrollment
Massachusetts
Massachusetts General Hospital, Boston, MA 02114
-
Closed to Enrollment
Massachusetts
Boston Children's Hospital, Brigham & Women's Hospital, Boston, MA 02115
-
Closed to Enrollment
Michigan
University of Michigan Health System, Ann Arbor, MI 48109
-
Closed to Enrollment
Minnesota
The Minnesota Cystic Fibrosis Center, Minneapolis, MN 55455
-
Closed to Enrollment
Missouri
Washington University School of Medicine, St. Louis, MO 63110
-
Closed to Enrollment
Missouri
SSM Health Saint Louis University Hospital, St. Louis, MO 63110
-
Closed to Enrollment
New York
Columbia University Cystic Fibrosis Program, New York, NY 10032
-
Closed to Enrollment
North Carolina
University of North Carolina at Chapel Hill, Chapel Hill, NC 27514
-
Closed to Enrollment
North Carolina
Atrium Health Pulmonary Care, Charlotte, NC 28204
-
Closed to Enrollment
Ohio
Nationwide Children's Hospital, Columbus, OH 43205
-
Closed to Enrollment
Ohio
Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center, Cleveland, OH 44106
-
Closed to Enrollment
Oregon
Oregon Health Sciences University, Portland, OR 97239
-
Closed to Enrollment
Pennsylvania
University of Pennsylvania, Philadelphia, PA 19104
-
Closed to Enrollment
Pennsylvania
University of Pittsburgh Medical Center, Pittsburgh, PA 15224
-
Closed to Enrollment
South Carolina
Medical University of South Carolina, Charleston, SC 29425
-
Closed to Enrollment
Tennessee
Vanderbilt University Medical Center, Nashville, TN 37232
-
Closed to Enrollment
Texas
University of Texas Southwestern, Dallas, TX 75390
-
Closed to Enrollment
Utah
Adult Cystic Fibrosis Center at the University of Utah, Salt Lake City, UT 84112
-
Closed to Enrollment
Washington
University of Washington Medical Center, Seattle, WA 98195
-
Closed to Enrollment
Wisconsin
Froedtert & Medical College of Wisconsin, Milwaukee, WI 53226
Eligibility
See other primary eligibility criteria for more information.
-
Age:
18 Years to 75 Years -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Other Primary Eligibility Criteria
Adults with CF 40 years of age or older, without history of transplant, or adults with CF age 30 or older who have had a transplant. Adults must be eligible for routine colon cancer screening and referred for screening or surveillance colonoscopy for colorectal cancer.

CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More